Tekla Life Sciences Investors (HQL) — Tangible Net Worth Ratio
Tekla Life Sciences Investors (HQL) has a Tangible Net Worth Ratio of 100.0% as of March 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($560.83 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Tekla Life Sciences Investors equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tekla Life Sciences Investors Tangible Net Worth Ratio (1996–2025)
This chart shows how Tekla Life Sciences Investors's Tangible Net Worth Ratio has changed across 28 annual periods from 1996 to 2025. As of March 2026, the ratio stands at 100.0%, reflecting net assets of $560.83 Million with intangible assets of $0.00 USD. For live market cap and overall valuation, see Tekla Life Sciences Investors (HQL) market capitalisation.
Annual Tangible Net Worth Ratio for Tekla Life Sciences Investors (1996–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Tekla Life Sciences Investors from 1996 to 2025, covering 28 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See how much free cash does Tekla Life Sciences Investors generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $513.66 Million | $0.00 | $515.38 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $459.69 Million | $0.00 | $460.58 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $401.93 Million | $0.00 | $402.60 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $397.90 Million | $0.00 | $414.73 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $523.44 Million | $0.00 | $534.19 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $483.57 Million | $0.00 | $484.17 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $384.16 Million | $0.00 | $386.98 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $475.49 Million | $0.00 | $478.47 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $466.35 Million | $0.00 | $468.33 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $414.97 Million | $0.00 | $417.63 Million | ▲ +0.0 pp |
| 2015 | 100.0% | $462.84 Million | $0.00 | $467.85 Million | ▲ +0.0 pp |
| 2014 | 100.0% | $444.09 Million | $0.00 | $444.84 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $302.29 Million | $0.00 | $302.82 Million | ▲ +0.0 pp |
| 2012 | 100.0% | $227.08 Million | $0.00 | $227.48 Million | ▲ +0.0 pp |
| 2011 | 100.0% | $170.60 Million | $0.00 | $171.60 Million | ▲ +0.0 pp |
| 2010 | 100.0% | $251.40 Million | $0.00 | $256.80 Million | ▲ +0.0 pp |
| 2009 | 100.0% | $248.60 Million | $0.00 | $265.10 Million | ▲ +0.0 pp |
| 2008 | 100.0% | $277.80 Million | $0.00 | $281.00 Million | ▲ +0.0 pp |
| 2007 | 100.0% | $308.00 Million | $0.00 | $309.10 Million | ▲ +0.0 pp |
| 2006 | 100.0% | $268.10 Million | $0.00 | $270.80 Million | ▲ +0.0 pp |
| 2005 | 100.0% | $229.30 Million | $0.00 | $230.30 Million | ▲ +0.0 pp |
| 2004 | 100.0% | $191.80 Million | $0.00 | $193.10 Million | ▲ +0.0 pp |
| 2003 | 100.0% | $190.40 Million | $0.00 | $193.00 Million | ▲ +0.0 pp |
| 2002 | 100.0% | $157.60 Million | $0.00 | $157.90 Million | ▲ +0.0 pp |
| 2001 | 100.0% | $215.10 Million | $0.00 | $215.90 Million | ▲ +0.0 pp |
| 1998 | 100.0% | $100.00 Million | $0.00 | $101.40 Million | ▲ +0.0 pp |
| 1997 | 100.0% | $132.00 Million | $0.00 | $132.20 Million | ▲ +0.0 pp |
| 1996 | 100.0% | $123.10 Million | $0.00 | $123.70 Million | — |